These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37643779)

  • 1. Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing.
    Agiannitopoulos K; Pepe G; Tsaousis GN; Potska K; Bouzarelou D; Katseli A; Ntogka C; Meintani A; Tsoulos N; Giassas S; Venizelos V; Markopoulos C; Iosifidou R; Karageorgopoulou S; Christodoulou C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Kabletsas E; Psyrri A; Ziogas D; Lalla E; Koumarianou A; Anastasakou K; Papadimitriou C; Ozmen V; Tansan S; Kaban K; Ozatli T; Eniu DT; Chiorean A; Blidaru A; Rinsma M; Papadopoulou E; Nasioulas G
    Cancer Genomics Proteomics; 2023; 20(5):448-455. PubMed ID: 37643779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients.
    Rutkowska L; Pinkier I; Sałacińska K; Kępczyński Ł; Salachna D; Lewek J; Banach M; Matusik P; Starostecka E; Lewiński A; Płoski R; Stawiński P; Gach A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
    Yao R; Yu T; Qing Y; Wang J; Shen Y
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
    Schmidt AY; Hansen TVO; Ahlborn LB; Jønson L; Yde CW; Nielsen FC
    J Mol Diagn; 2017 Nov; 19(6):809-816. PubMed ID: 28822785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer.
    Agaoglu NB; Unal B; Akgun Dogan O; Zolfagharian P; Sharifli P; Karakurt A; Can Senay B; Kizilboga T; Yildiz J; Dinler Doganay G; Doganay L
    Expert Rev Mol Diagn; 2022 Feb; 22(2):239-246. PubMed ID: 35240897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples.
    Zakrzewski F; Gieldon L; Rump A; Seifert M; Grützmann K; Krüger A; Loos S; Zeugner S; Hackmann K; Porrmann J; Wagner J; Kast K; Wimberger P; Baretton G; Schröck E; Aust D; Klink B
    BMC Cancer; 2019 Apr; 19(1):396. PubMed ID: 31029168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of CNVs using NGS data improves mutation detection yield and decreases costs in genetic testing for hereditary cancer.
    Moreno-Cabrera JM; Del Valle J; Feliubadaló L; Pineda M; González S; Campos O; Cuesta R; Brunet J; Serra E; Capellà G; Gel B; Lázaro C
    J Med Genet; 2022 Jan; 59(1):75-78. PubMed ID: 33219106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Easy-to-Use Approach to Detect CNV From Targeted NGS Data: Identification of a Novel Pathogenic Variant in MO Disease.
    Corsini S; Pedrini E; Patavino C; Gnoli M; Lanza M; Sangiorgi L
    Front Endocrinol (Lausanne); 2022; 13():874126. PubMed ID: 35837302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of next-generation sequencing gene panel diagnostics including copy-number variation analysis in 810 patients suspected of heritable thoracic aortic disorders.
    Overwater E; Marsili L; Baars MJH; Baas AF; van de Beek I; Dulfer E; van Hagen JM; Hilhorst-Hofstee Y; Kempers M; Krapels IP; Menke LA; Verhagen JMA; Yeung KK; Zwijnenburg PJG; Groenink M; van Rijn P; Weiss MM; Voorhoeve E; van Tintelen JP; Houweling AC; Maugeri A
    Hum Mutat; 2018 Sep; 39(9):1173-1192. PubMed ID: 29907982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH.
    Hackmann K; Kuhlee F; Betcheva-Krajcir E; Kahlert AK; Mackenroth L; Klink B; Di Donato N; Tzschach A; Kast K; Wimberger P; Schrock E; Rump A
    Breast Cancer Res Treat; 2016 Oct; 159(3):585-90. PubMed ID: 27581129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Sequence and Copy Number Variants in Canadian Patient Cohort With Familial Cancer Syndromes Using a Unique Next Generation Sequencing Based Approach.
    Bhai P; Levy MA; Rooney K; Carere DA; Reilly J; Kerkhof J; Volodarsky M; Stuart A; Kadour M; Panabaker K; Schenkel LC; Lin H; Ainsworth P; Sadikovic B
    Front Genet; 2021; 12():698595. PubMed ID: 34326862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. panelcn.MOPS: Copy-number detection in targeted NGS panel data for clinical diagnostics.
    Povysil G; Tzika A; Vogt J; Haunschmid V; Messiaen L; Zschocke J; Klambauer G; Hochreiter S; Wimmer K
    Hum Mutat; 2017 Jul; 38(7):889-897. PubMed ID: 28449315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer.
    Lepkes L; Kayali M; Blümcke B; Weber J; Suszynska M; Schmidt S; Borde J; Klonowska K; Wappenschmidt B; Hauke J; Kozlowski P; Schmutzler RK; Hahnen E; Ernst C
    Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33401422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting copy number variation in next generation sequencing data from diagnostic gene panels.
    Singh AK; Olsen MF; Lavik LAS; Vold T; Drabløs F; Sjursen W
    BMC Med Genomics; 2021 Aug; 14(1):214. PubMed ID: 34465341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of CNV detection tools for NGS panel data in genetic diagnostics.
    Moreno-Cabrera JM; Del Valle J; Castellanos E; Feliubadaló L; Pineda M; Brunet J; Serra E; Capellà G; Lázaro C; Gel B
    Eur J Hum Genet; 2020 Dec; 28(12):1645-1655. PubMed ID: 32561899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
    Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
    BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing.
    Mancini-DiNardo D; Judkins T; Kidd J; Bernhisel R; Daniels C; Brown K; Meek K; Craft J; Holladay J; Morris B; Roa BB
    BMC Med Genomics; 2019 Oct; 12(1):138. PubMed ID: 31623605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNV-RF Is a Random Forest-Based Copy Number Variation Detection Method Using Next-Generation Sequencing.
    Onsongo G; Baughn LB; Bower M; Henzler C; Schomaker M; Silverstein KA; Thyagarajan B
    J Mol Diagn; 2016 Nov; 18(6):872-881. PubMed ID: 27597741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of CNVs in NGS Data Using VS-CNV.
    Fortier N; Rudy G; Scherer A
    Methods Mol Biol; 2018; 1833():115-127. PubMed ID: 30039368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and properties of intragenic copy-number variation in Mendelian disease genes.
    Truty R; Paul J; Kennemer M; Lincoln SE; Olivares E; Nussbaum RL; Aradhya S
    Genet Med; 2019 Jan; 21(1):114-123. PubMed ID: 29895855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.